Integrated Safety Analysis of Vedolizumab for the Treatment of Ulcerative Colitis or Crohn's Disease

被引：0
|
作者：
Colombel, Jean-Frederic
Sands, Bruce E.
Feagan, Brian G.
Loftus, Edward V.
Sankoh, Serap
Fox, Irving
Parikh, Asit
Milch, Catherine
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [11] Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn’s Disease Patients Stratified by Age
    Vijay Yajnik
    Nabeel Khan
    Marla Dubinsky
    Jeffrey Axler
    Alexandra James
    Brihad Abhyankar
    Karen Lasch
    Advances in Therapy, 2017, 34 : 542 - 559
  • [12] Gastroenterology Vedolizumab as an Option in ulcerative Colitis and Crohn's Disease?
    Pommer, Peter
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (45) : 2284 - 2284
  • [13] Current position on Vedolizumab for ulcerative colitis and Crohn's disease
    Schreiber, S.
    Dignass, A. U.
    Hartmann, H.
    Kruis, W.
    Rogler, G.
    Siegmund, B.
    Stallmach, A.
    Witte, C.
    Bokemeyer, B.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2015, 53 (06): : 591 - 602
  • [14] Real world data on the effectiveness and safety of vedolizumab in the treatment of Crohn's disease and ulcerative colitis: the Edinburgh experience
    Plevris, N.
    Manship, T. A.
    Deekae, A.
    Jones, G. R.
    Noble, C. L.
    Satsangi, J.
    Shand, A. G.
    Arnott, I. D.
    Lees, C. W.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S288 - S289
  • [15] REAL WORLD DATA ON THE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN THE TREATMENT OF CROHN'S DISEASE AND ULCERATIVE COLITIS: THE EDINBURGH EXPERIENCE
    Plevris, N.
    Manship, T. A.
    Deekae, A.
    Jones, G. R.
    Noble, C. L.
    Satsangi, J.
    Shand, A. G.
    Amott, I. D.
    Lees, C. W.
    GUT, 2017, 66 : A123 - A124
  • [16] VEDOLIZUMAB IN THE TREATMENT OF CROHN'S DISEASE AND ULCERATIVE COLITIS - NON-TERTIARY REAL WORLD ANALYSIS
    Ritchie, Susan
    Maw, Frances
    Hussien, Mohammed
    Fletcher, Victoria
    Crissop, Linda
    Jordan, Sarah
    Dhar, Anjan
    GUT, 2019, 68 : A92 - A92
  • [17] Vedolizumab: An integrin-receptor antagonist for treatment of Crohn's disease and ulcerative colitis
    Hahn, Lindsay
    Beggs, Ashton
    Wahaib, Kristy
    Kodali, Leela
    Kirkwood, Vanessa
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (15) : 1271 - 1278
  • [18] Benefit-Risk Assessment of Vedolizumab in the Treatment of Crohn's Disease and Ulcerative Colitis
    Battat, Robert
    Ma, Christopher
    Jairath, Vipul
    Khanna, Reena
    Feagan, Brian G.
    DRUG SAFETY, 2019, 42 (05) : 617 - 632
  • [19] Concomitant azathioprine treatment effects vedolizumab treatment persistence in Crohn's Disease but not in Ulcerative Colitis
    Toruner, M.
    Guvenir, T.
    Er, R. E.
    Soykan, I.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 531 - 532
  • [20] The safety of vedolizumab for the treatment of ulcerative colitis
    Novak, Gregor
    Hindryckx, Pieter
    Khanna, Reena
    Jairath, Vipul
    Feagan, Brian G.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 501 - 507
12345